These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30167602)
1. A chemically engineered, stable oligomer mimic of amyloid β42 containing an oxime switch for fibril formation. Yamamoto M; Shinoda K; Ni J; Sasaki D; Kanai M; Sohma Y Org Biomol Chem; 2018 Sep; 16(35):6537-6542. PubMed ID: 30167602 [TBL] [Abstract][Full Text] [Related]
2. Elongation affinity, activation barrier, and stability of Aβ42 oligomers/fibrils in physiological saline. Rodriguez RA; Chen LY; Plascencia-Villa G; Perry G Biochem Biophys Res Commun; 2017 May; 487(2):444-449. PubMed ID: 28427941 [TBL] [Abstract][Full Text] [Related]
3. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of chemically-tethered amyloid-β segment trimer possessing amyloidogenic properties. Shinoda K; Sohma Y; Kanai M Bioorg Med Chem Lett; 2015 Aug; 25(15):2976-9. PubMed ID: 26048787 [TBL] [Abstract][Full Text] [Related]
5. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG; Nowick JS Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987 [TBL] [Abstract][Full Text] [Related]
6. Study on the inter- and intra-peptide salt-bridge mechanism of Aβ23-28 oligomer interaction with small molecules: QM/MM method. Boopathi S; Kolandaivel P Mol Biosyst; 2015 Jul; 11(7):2031-41. PubMed ID: 25973904 [TBL] [Abstract][Full Text] [Related]
7. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations. Nguyen P; Derreumaux P Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046 [TBL] [Abstract][Full Text] [Related]
8. Identifying the Template for Oligomer to Fibril Conversion for Amyloid-β (1-42) Oligomers using Hamiltonian Replica Exchange Molecular Dynamics. Saha D; Jana B Chemphyschem; 2022 Dec; 23(24):e202200393. PubMed ID: 36052514 [TBL] [Abstract][Full Text] [Related]
9. G37V mutation of Aβ42 induces a nontoxic ellipse-like aggregate: An in vitro and in silico study. Minh Thu TT; Huang SH; Tu LA; Fang ST; Li MS; Chen YC Neurochem Int; 2019 Oct; 129():104512. PubMed ID: 31374231 [TBL] [Abstract][Full Text] [Related]
10. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor. Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547 [TBL] [Abstract][Full Text] [Related]
11. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils. Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899 [TBL] [Abstract][Full Text] [Related]
12. Effect of pH on Aβ Zhao W; Ai H Chemphyschem; 2018 May; 19(9):1103-1116. PubMed ID: 29380494 [TBL] [Abstract][Full Text] [Related]
14. Preparation and Fractionation of Heterogeneous Aβ42 Oligomers with Different Aggregation Properties. Chen EW; Guo Z Methods Mol Biol; 2023; 2551():29-39. PubMed ID: 36310194 [TBL] [Abstract][Full Text] [Related]
15. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro. Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038 [TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulations to investigate the aggregation behaviors of the Abeta(17-42) oligomers. Zhao JH; Liu HL; Liu YF; Lin HY; Fang HW; Ho Y; Tsai WB J Biomol Struct Dyn; 2009 Feb; 26(4):481-90. PubMed ID: 19108587 [TBL] [Abstract][Full Text] [Related]
17. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation. Poduslo JF; Howell KG J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128 [TBL] [Abstract][Full Text] [Related]
18. The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide. Selivanova OM; Surin AK; Marchenkov VV; Dzhus UF; Grigorashvili EI; Suvorina MY; Glyakina AV; Dovidchenko NV; Galzitskaya OV J Alzheimers Dis; 2016 Sep; 54(2):821-30. PubMed ID: 27567850 [TBL] [Abstract][Full Text] [Related]
19. A long-lived Aβ oligomer resistant to fibrillization. Nick M; Wu Y; Schmidt NW; Prusiner SB; Stöhr J; DeGrado WF Biopolymers; 2018 Aug; 109(8):e23096. PubMed ID: 29319162 [TBL] [Abstract][Full Text] [Related]
20. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling. Gu L; Tran J; Jiang L; Guo Z J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]